Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125mg, 60 tablets per carton (10 blister cards containing 6 tablets each), Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC# 49884-306-02.
Published August 7, 2024 · Recall initiated: July 10, 2024
Summary
FDA records drug Class I recall D-0622-2024, published August 7, 2024 and initiated July 10, 2024. Recalling firm: Endo Pharmaceuticals, Inc.; Status: Terminated; Reported quantity: 8,139 cartons; Lot: Lot 550147301, Exp. 08/31/2026. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.
What to do
Voluntary: Firm initiated · Letter
Get an email if CLONAZEPAM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CLONAZEPAM
- Manufacturer
- Endo Pharmaceuticals, Inc.
- Distributor
- Nationwide in the USA and Puerto Rico
- Lot
- Lot 550147301, Exp. 08/31/2026
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClonazepam Orally Disintegrating Tablets, USP, 0.125 mg, C-IV, Rx Only, 60 tablets per carton (10 blisterJanuary 15, 2025
- FDAClonazepam Orally Disintegrating Tablets, USP, 1 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cardsJanuary 15, 2025
- FDAClonazepam Orally Disintegrating Tablet, USP, 2 mg, C-IV, Rx Only, 60 Tablets per carton, 10 blister cardsJanuary 15, 2025
- FDAClonazepam Orally Disintegrating Tablets, USP, 0.25 mg, C-IV, Rx Only, 60 tablets per carton (10 blister cardsJanuary 15, 2025
- FDAGlenmark, Azelaic Acid Gel, 15 %, 50 grams, Rx only, Manufactured by: Glenmark Pharmaceuticals Limited,August 7, 2024
- FDACiprofloxacin ophthalmic solution USP, 0.3% as base, package in bottles: a) 10 mL (NDC 69315-308-10), b) 2.5August 7, 2024
Questions about this recall
Was Clonazepam Orally Disintegrating Tablets, USP (C-IV) 0.125mg, 60 tablets per carton (10 blister cards containing 6 tablets each), Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC# 49884-306-02. recalled?
Yes. FDA published recall D-0622-2024 on August 7, 2024. Reported hazard: Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CLONAZEPAM.